1173120

Novartis Pharma S.A.S. - Centre de Biotechnologie — FEI 3004864869

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 19, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Huningue (France)

Additional Details

Mutual Recognition Agreement (MRA)